Beta-Glucan and Monoclonal Antibody in Treating Patients With Metastatic Neuroblastoma
Clinical trial NCT00037011 · COMPLETED
Trial details
- NCT number
- NCT00037011
- Sponsor
- Memorial Sloan Kettering Cancer Center
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2001-11-01
- Primary completion
- 2005-01-01
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.